LRP6 Bidirectionally Regulates Insulin Sensitivity through Insulin Receptor and S6K Signaling in Rats with CG-IUGR

Abstract

Objective

Intrauterine growth restriction followed by postnatal catch-up growth (CG-IUGR) increases the risk of insulin resistance-related diseases. Low-density lipoprotein receptor-related protein 6 (LRP6) plays a substantial role in glucose metabolism. However, whether LRP6 is involved in the insulin resistance of CG-IUGR is unclear. This study aimed to explore the role of LRP6 in insulin signaling in response to CG-IUGR.

Methods

The CG-IUGR rat model was established via a maternal gestational nutritional restriction followed by postnatal litter size reduction. The mRNA and protein expression of the components in the insulin pathway, LRP6/β-catenin and mammalian target of rapamycin (mTOR)/S6 kinase (S6K) signaling, was determined. Liver tissues were immunostained for the expression of LRP6 and β-catenin. LRP6 was overexpressed or silenced in primary hepatocytes to explore its role in insulin signaling.

Results

Compared with the control rats, CG-IUGR rats showed higher homeostasis model assessment for insulin resistance (HOMA-IR) index and fasting insulin level, decreased insulin signaling, reduced mTOR/S6K/ insulin receptor substrate-1 (IRS-1) serine307 activity, and decreased LRP6/β-catenin in the liver tissue. The knockdown of LRP6 in hepatocytes from appropriate-for-gestational-age (AGA) rats led to reductions in insulin receptor (IR) signaling and mTOR/S6K/IRS-1 serine307 activity. In contrast, LRP6 overexpression in hepatocytes of CG-IUGR rats resulted in elevated IR signaling and mTOR/S6K/IRS-1 serine307 activity.

Conclusion

LRP6 regulated the insulin signaling in the CG-IUGR rats via two distinct pathways, IR and mTOR-S6K signaling. LRP6 may be a potential therapeutic target for insulin resistance in CG-IUGR individuals.

Keywords

intrauterine growth restriction followed by postnatal catch-up growth / insulin signaling / lipoprotein receptor-related protein 6 / Wnt signaling / mammalian target of rapamycin/S6 kinase signaling

References

[1] SharmaD, ShastriS, FarahbakhshN, et al.. Intrauterine growth restriction — part 1. J Matern Fetal Neonatal Med, 2016, 29(24): 3977-3987

[2] XieX, LinT, ZhangM, et al.. IUGR with infantile overnutrition programs an insulin-resistant phenotype through DNA methylation of peroxisome proliferator-activated receptor-γ coactivator-1α in rats. Pediatr Res, 2015, 77(5): 625-632

[3] CaseyPH, Whiteside-mansellL, BarrettK, et al.. Impact of prenatal and/or postnatal growth problems in low birth weight preterm infants on school-age outcomes: an 8-year longitudinal evaluation. Pediatrics, 2006, 118(3): 1078-1086

[4] OngKK. Catch-up growth in small for gestational age babies: good or bad?. Curr Opin Endocrinol Diabetes Obes, 2007, 14(1): 30-34

[5] HermannGM, MillerRL, ErkonenGE, et al.. Neonatal catch up growth increases diabetes susceptibility but improves behavioral and cardiovascular outcomes of low birth weight male mice. Pediatr Res, 2009, 66(1): 53-58

[6] Fernandez-twinnDS, OzanneSE. Early life nutrition and metabolic programming. Ann N Y Acad Sci, 2010, 1212: 78-96

[7] CianfaraniS, AgostoniC, BedogniG, et al.. Effect of intrauterine growth retardation on liver and long-term metabolic risk. Int J Obes, 2012, 36(10): 1270-1277

[8] BerendsLM, Fernandez-twinnDS, Martin-gronertMS, et al.. Catch-up growth following intra-uterine growth-restriction programmes an insulin-resistant phenotype in adipose tissue. Int J Obes, 2013, 37(8): 1051-1057

[9] SimmonsRA, TempletonLJ, GertzSJ. Intrauterine growth retardation leads to the development of type 2 diabetes in the rat. Diabetes, 2001, 50(10): 2279-2286

[10] BerendsLM, DeardenL, TungYCL, et al.. Programming of central and peripheral insulin resistance by low birthweight and postnatal catch-up growth in male mice. Diabetologia, 2018, 61(10): 2225-2234

[11] OngKK, AhmedML, EmmettPM, et al.. Association between postnatal catch-up growth and obesity in childhood: prospective cohort study. BMJ, 2000, 320(7240): 967-971

[12] DuanC, LiuM, XuH, et al.. Decreased expression of GLUT4 in male CG-IUGR rats may play a vital role in their increased susceptibility to diabetes mellitus in adulthood. Acta biochimica et biophysica Sinica, 2016, 48(10): 872-882

[13] HofmanPL, ReganF, HarrisM, et al.. The metabolic consequences of prematurity. Growth Horm IGF Res, 2004, 14(Suppl A): S136-139

[14] MericqV. Low birth weight and endocrine dysfunction in postnatal life. Pediatr Endocrinol Rev, 2006, 4(1): 3-14

[15] LongoS, BollaniL, DecembrinoL, et al.. Short-term and long-term sequelae in intrauterine growth retardation (IUGR). J Matern Fetal Neonatal Med, 2013, 26(3): 222-225

[16] Abou ZikiMD, ManiA. The interplay of canonical and noncanonical Wnt signaling in metabolic syndrome. Nutr Res, 2019, 70: 18-25

[17] LiuW, SinghR, ChoiCS, et al.. Low density lipoprotein (LDL) receptor-related protein 6 (LRP6) regulates body fat and glucose homeostasis by modulating nutrient sensing pathways and mitochondrial energy expenditure. J Biol Chem, 2012, 287(10): 7213-7223

[18] AuDT, MiglioriniM, StricklandDK, et al.. Macrophage LRP1 Promotes Diet-Induced Hepatic Inflammation and Metabolic Dysfunction by Modulating Wnt Signaling. Mediators Inflamm, 2018, 2018: 790-2841

[19] WangZM, LuoJQ, XuLY, et al.. Harnessing low-density lipoprotein receptor protein 6 (LRP6) genetic variation and Wnt signaling for innovative diagnostics in complex diseases. Pharmacogenomics J, 2018, 18(3): 351-358

[20] SinghR, SmithE, FathzadehM, et al.. Rare nonconservative LRP6 mutations are associated with metabolic syndrome. Hum Mutat, 2013, 34(9): 1221-1225

[21] SinghR, De AguiarRB, NaikS, et al.. LRP6 enhances glucose metabolism by promoting TCF7L2-dependent insulin receptor expression and IGF receptor stabilization in humans. Cell Metab, 2013, 17(2): 197-209

[22] MaoZ, ZhangW. Role of mTOR in Glucose and Lipid Metabolism. Int J Mol Sci, 2018, 19(7): 2043

[23] YoonMS. The Role of Mammalian Target of Rapamycin (mTOR) in Insulin Signaling. Nutrients, 2017, 9(11): 1176

[24] UmSH, FrigerioF, WatanabeM, et al.. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature, 2004, 431(7005): 200-205

[25] GualP, Le Marchand-brustelY, TantiJ F. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie, 2005, 87(1): 99-109

[26] RuiL, AguirreV, KimJK, et al.. Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J Clin Invest, 2001, 107(2): 181-189

[27] KangS. Low-density lipoprotein receptor-related protein 6-mediated signaling pathways and associated cardiovascular diseases: diagnostic and therapeutic opportunities. Hum Genet, 2020, 139(4): 447-459

[28] LiL, XueJ, WanJ, et al.. LRP6 Knockdown Ameliorates Insulin Resistance via Modulation of Autophagy by Regulating GSK3β Signaling in Human LO2 Hepatocytes. Front Endocrinol (Lausanne), 2019, 10: 73

[29] SantoleriD, TitchenellPM. Resolving the Paradox of Hepatic Insulin Resistance. Cell Mol Gastroenterol Hepatol, 2019, 7(2): 447-456

[30] FerrisHA, KahnCR. Unraveling the Paradox of Selective Insulin Resistance in the Liver: the Brain-Liver Connection. Diabetes, 2016, 65(6): 1481-1483

[31] LiaoL, ZhengR, WangC, et al.. The influence of down-regulation of suppressor of cellular signaling proteins by RNAi on glucose transport of intrauterine growth retardation rats. Pediatr Res, 2011, 69(6): 497-503

[32] YeJ, ZhengR, WangQ, et al.. Downregulating SOCS3 with siRNA ameliorates insulin signaling and glucose metabolism in hepatocytes of IUGR rats with catch-up growth. Pediatr Res, 2012, 72(6): 550-559

[33] ZhengRD, LiaoLH, YeJ, et al.. Effects of SOCS 1/3 gene silencing on the expression of C/EBPα and PPARγ during differentiation and maturation of rat preadipocytes. Pediatr Res, 2013, 73(3): 263-267

[34] HaffnerSM, MiettinenH, SternMP. The homeostasis model in the San Antonio Heart Study. Diabetes Care, 1997, 20(7): 1087-1092

[35] Shen L, Hillebrand A, Wang DQ, et al. Isolation and primary culture of rat hepatic cells. J Vis Exp, 2012,(64):3917

[36] XuZ, HeX, ShiX, et al.. Analysis of differentially expressed genes among human hair follicle-derived iPSCs, induced hepatocyte-like cells, and primary hepatocytes. Stem Cell Res Ther, 2018, 9(1): 211

[37] HoraiS, YanagiK, KanameT, et al.. Establishment of a primary hepatocyte culture from the small Indian mongoose (Herpestes auropunctatus) and distribution of mercury in liver tissue. Ecotoxicology, 2014, 23(9): 1681-1689

[38] BaeEJ, YangYM, KimJW, et al.. Identification of a novel class of dithiolethiones that prevent hepatic insulin resistance via the adenosine monophosphate-activated protein kinase-p70 ribosomal S6 kinase-1 pathway. Hepatology, 2007, 46(3): 730-739

[39] HeB, WenY, HuS, et al.. Prenatal caffeine exposure induces liver developmental dysfunction in offspring rats. J Endocrinol, 2019, 242(3): 211-226

[40] YoungrenJF. Regulation of insulin receptor function. Cell Mol Life Sci, 2007, 64(7–8): 873-891

[41] DrazninB. Molecular mechanisms of insulin resistance: serine phosphorylation of insulin receptor substrate-1 and increased expression of p85alpha: the two sides of a coin. Diabetes, 2006, 55(8): 2392-2397

[42] Smadja-lamèreN, ShumM, DélérisP, et al.. Insulin activates RSK (p90 ribosomal S6 kinase) to trigger a new negative feedback loop that regulates insulin signaling for glucose metabolism. J Biol Chem, 2013, 288(43): 31165-31176

[43] ChenY, HuangL, QiX, et al.. Insulin Receptor Trafficking: Consequences for Insulin Sensitivity and Diabetes. Int J Mol Sci, 2019, 20(20): 5007

[44] Ferenc K, Pietrzak P, Wierzbicka M, et al. Alterations in the liver of intrauterine growth retarded piglets may predispose to development of insulin resistance and obesity in later life. J Physiol Pharmacol, 2018,69(2)

[45] SweMT, PongchaidechaA, ChatsudthipongV, et al.. Molecular signaling mechanisms of renal gluconeogenesis in nondiabetic and diabetic conditions. J Cell Physiol, 2019, 234(6): 8134-8151

[46] BarthelA, SchmollD. Novel concepts in insulin regulation of hepatic gluconeogenesis. Am J Physiol Endocrinol Metab, 2003, 285(4): E685-E692

[47] MericqV, Martinez-aguayoA, UauyR, et al.. Long-term metabolic risk among children born premature or small for gestational age. Nat Rev Endocrinol, 2017, 13(1): 50-62

[48] MichaelMD, KulkarniRN, PosticC, et al.. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell, 2000, 6(1): 87-97

[49] ZhangW, ShenXY, ZhangWW, et al.. Di-(2-ethylhexyl) phthalate could disrupt the insulin signaling pathway in liver of SD rats and L02 cells via PPARγ. Toxicol Appl Pharmacol, 2017, 316: 17-26

[50] ChengPW, ChenYY, ChengWH, et al.. Wnt Signaling Regulates Blood Pressure by Downregulating a GSK-3β-Mediated Pathway to Enhance Insulin Signaling in the Central Nervous System. Diabetes, 2015, 64(10): 3413-3424

[51] LiR, OuJ, LiL, et al.. The Wnt Signaling Pathway Effector TCF7L2 Mediates Olanzapine-Induced Weight Gain and Insulin Resistance. Front Pharmacol, 2018, 9: 379

[52] Karczewska-kupczewskaM, StefanowiczM, MatulewiczN, et al.. Wnt Signaling Genes in Adipose Tissue and Skeletal Muscle of Humans With Different Degrees of Insulin Sensitivity. J Clin Endocrinol Metabol, 2016, 101(8): 3079-3087

[53] PalsgaardJ, EmanuelliB, WinnayJN, et al.. Cross-talk between insulin and Wnt signaling in preadipocytes: role of Wnt co-receptor low density lipoprotein receptor-related protein-5 (LRP5). J Biol Chem, 2012, 287(15): 12016-12026

[54] YoonJC, NgA, KimBH, et al.. Wnt signaling regulates mitochondrial physiology and insulin sensitivity. Genes Dev, 2010, 24(14): 1507-1518

[55] ManiA, RadhakrishnanJ, WangH, et al.. LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science, 2007, 315(5816): 1278-1282

[56] BronsveldHK, De BruinML, WesselingJ, et al.. The association of diabetes mellitus and insulin treatment with expression of insulin-related proteins in breast tumors. BMC Cancer, 2018, 18(1): 224

[57] QiaoS, MaoG, LiH, et al.. DPP-4 Inhibitor Sitagliptin Improves Cardiac Function and Glucose Homeostasis and Ameliorates β-Cell Dysfunction Together with Reducing S6K1 Activation and IRS-1 and IRS-2 Degradation in Obesity Female Mice. J Diabetes Res, 2018, 2018: 3641516

[58] GuiducciL, IervasiG, Quinones-galvanA. On the paradox insulin resistance/insulin hypersensitivity and obesity: two tales of the same history. Expert Rev Cardiovasc Ther, 2014, 12(6): 637-642

[59] EhrenkranzRA, DusickAM, VohrBR, et al.. Growth in the neonatal intensive care unit influences neurodevelopmental and growth outcomes of extremely low birth weight infants. Pediatrics, 2006, 117(4): 1253-1261

[60] CunhaAC, PereiraRO, PereiraMJ, et al.. Long-term effects of overfeeding during lactation on insulin secretion—the role of GLUT-2. J Nutr Biochem, 2009, 20(6): 435-442

[61] ConceicaoEP, TrevenzoliIH, OliveiraE, et al.. Higher white adipocyte area and lower leptin production in adult rats overfed during lactation. Horm Metab Res, 2011, 43(7): 513-516

[62] FaienzaM F, BrunettiG, VenturaA, et al.. Nonalcoholic fatty liver disease in prepubertal children born small for gestational age: influence of rapid weight catch-up growth. Horm Research in Paediatr, 2013, 79(2): 103-109